logo
Wuhan Desheng Biochemical Technology Co., Ltd
Wuhan Desheng Biochemical Technology Co., Ltd
Products
Home /

Products

Warning of collaborative failure: Analysis of compatibility issues between CAPS and common additives

Product Details

Place of Origin: EZHOU,CHINA

Brand Name: DESHENG

Certification: ISO9001:2008

Payment & Shipping Terms

Minimum Order Quantity: 10g

Price: Negotiable

Packaging Details: Plastic Bottle or Aluminium Film

Delivery Time: 1~3 DAYS AFTER RECEIVING PAYMENT

Payment Terms: T/T,L/C,D/A,D/P,Western Union,MoneyGram,paypal

Supply Ability: 100kg/month

Get Best Price
Contact Now
Specifications
Highlight:

CAPS buffer

,

3- (cyclohexylamine) -1-propanesulfonic acid

,

1135-40-6

Appearance:
White Crystal Powder
Purity:
>99.0%
MW:
221.32
Formula:
C9H19NO3S
Cas:
1135-40-6
Name:
CAPS
Appearance:
White Crystal Powder
Purity:
>99.0%
MW:
221.32
Formula:
C9H19NO3S
Cas:
1135-40-6
Name:
CAPS
Description
Warning of collaborative failure: Analysis of compatibility issues between CAPS and common additives

In biopharmaceutical and molecular biology experiments, CAPS buffer is often used in combination with reducing agents, chelating agents, surfactants, or protectants. When certain additive combinations are not appropriate, the system may experience synergistic failures such as decreased buffer capacity, precipitation formation, or loss of target molecule activity. This type of problem has strong concealment and high investigation costs, and deserves systematic attention from experimenters.


Product Name

3- (cyclohexylamine) -1-propanesulfonic acid

Chemical Abbreviation

CAPS buffer

CAS Number

1135-40-6

Product Appearance

White crystalline powder

Molecular Weight

221.32

Molecular Formula

C9H19NO3S

Density

1.19g/cm3

Melting Point

324℃

Storage Conditions

Room temperature, away from light and moisture

Standard Packaging

25KG/Cardboard bucket

Water-soluble

9 g/100 mL (20℃)

Manufacturer

Hubei New Desheng


Buffer capacity attenuation in the presence of metal ions


Some experimental schemes incorporate trace amounts of divalent metal ions as enzyme cofactors into the CAPS system. However, the amino and sulfonic acid groups in CAPS molecules have a coordination tendency towards calcium and magnesium ions. Although this complexation does not produce precipitation, it consumes free metal ions and alters the effective dissociation equilibrium of CAPS. There are cases showing that in protein stabilization experiments containing calcium ions, the actual pH of CAPS buffer deviates from the set value after two hours, while it remains stable when prepared separately. Upon investigation, it was found that the buffering contribution of the binding state between metal ions and CAPS was weak, resulting in a dilution of the total capacity. The response plan includes using buffering agents that do not chelate with metal ions, or pre sealing the coordination sites of CAPS with saturation.


Warning of collaborative failure: Analysis of compatibility issues between CAPS and common additives 0

CAPS powder


Interference of unknown degradation products when reducing agents coexist


Dithiothreitol or β - mercaptoethanol is often used in combination with CAPS to maintain the free thiol groups of proteins. But under alkaline conditions and residual oxygen, CAPS will slightly catalyze the oxidative self polymerization of thiol reducing agents, generating large molecular by-products with UV absorption. In a certain monoclonal antibody purification process, after replacing the freshly prepared CAPS-DTT buffer, there was a fluctuation in the proportion of product charge variants, which was ultimately attributed to the accumulation of oxidation products caused by prolonged storage of the buffer. The improvement measures are to strictly control the degassing process and add the reducing agent as needed to shorten the storage time after mixing.


Insoluble complexes induced by surfactants


Non ionic surfactants such as Triton X-100 are often used in combination with CAPS for membrane protein solubilization. But experiments have found that when the temperature drops below room temperature and the concentration of surfactants is high, hydrogen bond mediated aggregation occurs between CAPS and polyoxyethylene chains, forming a milky white turbidity. The turbidity cannot be removed by filtration and will also adsorb and lose trace proteins in the sample. After replacing with alkyl glycoside surfactants, the phenomenon disappeared, indicating that visual compatibility testing must be performed when using a new batch combination for the first time.


PH Drift Illusion in Coexistence of Chelating Agents


EDTA is often added to the CAPS system to shield trace heavy metals. However, EDTA itself is a polybasic acid, and its dissociation state is greatly affected by pH. Within the alkaline range of CAPS, deprotonation of EDTA will release additional hydrogen ions, resulting in more alkaline solution consumption during pH adjustment during preparation. Even more subtly, when the temperature changes, the pKa shift direction of EDTA is opposite to that of CAPS, and the combination of the two causes bidirectional drift in the actual working pH. The repeatability of a certain nucleic acid hybridization experiment is poor, and it has been confirmed through analysis that the synergistic effect is amplified by the temperature difference in the laboratory during different seasons. The solution is to reduce EDTA to the effective minimum concentration and minimize its intervention in the buffer system.


The interaction between polyols and CAPS affects freeze-drying and reconstitution


In the diagnostic reagent freeze-drying process, sucrose or trehalose coexist with CAPS. Under certain formulas, the reconstitution time of freeze-dried cake blocks is significantly prolonged and the pH after reconstitution is low. Research has found that the freeze concentration effect causes weak intermolecular interactions between CAPS and polyols, altering the ratio of crystalline and amorphous phases, affecting both the rate of reconstitution and the local concentration of buffer salts. The problem was improved by adjusting the pre freezing rate or changing the relative ratio of polyols to CAPS.


Systematic Approach and Summary of Failure Investigation


In the face of collaborative failure, it is recommended to use a univariate controlled experiment: first test the pH, clarity, and spectral signal of the CAPS standalone system, then add each additive sequentially, and re evaluate after each incubation step. Pay close attention to changes in appearance, pH shift, and the attribution of abnormal peaks. Simultaneously establish a rapid pre-test process for additive mixing, recording the source and purity information of each batch, as trace impurities are often triggering factors.


Warning of collaborative failure: Analysis of compatibility issues between CAPS and common additives 1

Product packaging


Understanding the underlying mechanisms of these interactions can help avoid pitfalls during the formulation design phase. When experimental abnormalities occur, expanding the focus from a single component to the entire component interaction network can often more efficiently locate the root cause.

As a supplier of CAPS buffering agents, Hubei Xindesheng ensures that each batch of CAPS buffering agents has stable performance and a purity of over 99% through its processes and strict quality control system. The company has a professional R&D team that constantly explores and optimizes production processes, improves product quality, and meets increasingly diverse market demands. At the same time, Xindesheng also provides attentive customer service, offering professional technical consultation and solutions to customers. If you are interested, please feel free to click on the website for consultation at any time!

 

 

Send your inquiry
Please send us your request and we will reply to you as soon as possible.
Send